Treatment of Cerebral Tuberculosis
Treatment Regimen
- For cerebral tuberculoma without meningitis, a 12-month regimen of rifampicin and isoniazid, supplemented by pyrazinamide and a fourth drug for at least the first two months is recommended 1, 2
- Rifampicin (10 mg/kg, up to 600 mg daily), isoniazid (5 mg/kg, up to 300 mg daily), and pyrazinamide (35 mg/kg, up to 2 g daily) are used in the initial phase 3
- Ethambutol (15 mg/kg daily) or streptomycin can be used as the fourth drug in the initial phase 1, 2
- Rifampicin and isoniazid should be continued for a total treatment duration of 12 months 1, 2
Drug Selection Considerations
- Isoniazid, pyrazinamide, and prothionamide/ethionamide penetrate well into the cerebrospinal fluid 1
- Rifampicin penetrates less well into the cerebrospinal fluid but is a critical component of the regimen 1, 2
- Streptomycin and ethambutol only penetrate in adequate concentrations when the meninges are inflamed in the early stage of treatment 1
- Intrathecal administration of streptomycin is unnecessary 1
Corticosteroid Therapy
- Corticosteroids are recommended for more severe disease (stages II and III) 1, 2
- High-dose corticosteroid treatment (prednisolone 60 mg/day initially, tapered over several weeks) has shown clear benefit 1, 4
Special Considerations
- If pyrazinamide is omitted or cannot be tolerated, treatment should be prolonged to 18 months 1
- Ethambutol should be used with caution in unconscious patients as visual acuity cannot be tested 1
- The fourth drug in the initial phase can be streptomycin, ethambutol, or ethionamide 1
Monitoring
- Response to therapy should be monitored clinically and with neuroimaging 5
Pediatric Considerations
- Children with tuberculous meningitis should be treated for a minimum of 12 months with rifampicin and isoniazid, with an initial two months of pyrazinamide and a fourth drug (streptomycin or ethambutol) 6
- Dosages should be adjusted according to weight and may need to be recalculated with weight gain 6
- Supplemental pyridoxine is not necessary except for breast-fed infants and malnourished children 6
Use of Streptomycin as the Fourth Drug in the Initial Intensive Phase of Tuberculous Meningitis
Primary Indication
- Streptomycin may be employed as the fourth drug in the first 2‑month intensive phase of tuberculous meningitis when ethambutol cannot be used (e.g., in patients who are unconscious and cannot be monitored for visual toxicity) or when regional streptomycin resistance is low. 7, 8, 9
Alternative Fourth‑Drug Options
- When ethambutol (15 mg/kg daily orally) is contraindicated, streptomycin (15 mg/kg daily intramuscularly) can substitute as the fourth drug alongside isoniazid, rifampicin, and pyrazinamide during the initial 2‑month period. 7, 8
Geographic Considerations
- In settings where streptomycin resistance is uncommon, streptomycin remains an appropriate fourth‑drug choice for the intensive phase. 10, 11
- In regions with high streptomycin resistance, alternative aminoglycosides such as kanamycin, amikacin, or capreomycin should be selected instead of streptomycin. 10, 11
Contraindications & Toxicity
- Streptomycin is ototoxic and must be avoided in pregnancy because of the risk of fetal hearing loss. 7, 12
- In patients with renal impairment, streptomycin dosage should be reduced and serum drug concentrations monitored to mitigate toxicity. 12
Treatment Regimen When Using Streptomycin
Intensive phase (first 2 months):
Continuation phase (subsequent 10 months): Isoniazid + Rifampicin alone, completing a total of 12 months of therapy. 10, 7, 11